Jung Yul Kim

Title: Innovations by Jung Yul Kim in Cancer Research

Introduction

Jung Yul Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer research, particularly in the regulation of cancer stem cell growth. His innovative work has the potential to impact cancer treatment and therapy.

Latest Patents

Jung Yul Kim holds a patent titled "Method for regulating cancer stem cell growth by inhibiting phosphorylation of 120th threonine residue of TSPYL5 protein." This invention relates to a peptide that suppresses the phosphorylation of threonine (T120), the 120th residue of TSPYL5 (testis-specific Y-like protein 5). The inventors constructed T120D, a mutant of the 120th residue threonine (T120) of TSPYL5, and T120A-TSPYL5 gene to investigate the effect of phosphorylation on the T120 residue. The results showed that wild-type TSPYL5 and T120D moved into the nucleus, while T120A-TSPYL5 remained in the cytoplasm. This research indicates that the peptide can effectively inhibit cancer cell growth, metastasis, and cancer stem cell growth.

Career Highlights

Jung Yul Kim is affiliated with the Korea Atomic Energy Research Institute, where he continues to advance his research in cancer biology. His work has garnered attention for its innovative approach to understanding and regulating cancer stem cells.

Collaborations

Some of his notable coworkers include In Gyu Kim and Seo Yeon Kim, who have contributed to his research endeavors.

Conclusion

Jung Yul Kim's innovative research and patent in cancer stem cell regulation highlight his significant contributions to the field. His work has the potential to lead to new therapeutic strategies in cancer treatment.